Bromine in PDB 2oxd: Protein Kinase CK2 in Complex with Tetrabromobenzoimidazole K17, K22 and K32 Inhibitors
Enzymatic activity of Protein Kinase CK2 in Complex with Tetrabromobenzoimidazole K17, K22 and K32 Inhibitors
All present enzymatic activity of Protein Kinase CK2 in Complex with Tetrabromobenzoimidazole K17, K22 and K32 Inhibitors:
2.7.11.1;
Protein crystallography data
The structure of Protein Kinase CK2 in Complex with Tetrabromobenzoimidazole K17, K22 and K32 Inhibitors, PDB code: 2oxd
was solved by
R.Battistutta,
G.Zanotti,
L.Cendron,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
69.17 /
2.30
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
142.148,
60.316,
46.238,
90.00,
103.56,
90.00
|
R / Rfree (%)
|
22.1 /
27.3
|
Bromine Binding Sites:
The binding sites of Bromine atom in the Protein Kinase CK2 in Complex with Tetrabromobenzoimidazole K17, K22 and K32 Inhibitors
(pdb code 2oxd). This binding sites where shown within
5.0 Angstroms radius around Bromine atom.
In total 4 binding sites of Bromine where determined in the
Protein Kinase CK2 in Complex with Tetrabromobenzoimidazole K17, K22 and K32 Inhibitors, PDB code: 2oxd:
Jump to Bromine binding site number:
1;
2;
3;
4;
Bromine binding site 1 out
of 4 in 2oxd
Go back to
Bromine Binding Sites List in 2oxd
Bromine binding site 1 out
of 4 in the Protein Kinase CK2 in Complex with Tetrabromobenzoimidazole K17, K22 and K32 Inhibitors
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 1 of Protein Kinase CK2 in Complex with Tetrabromobenzoimidazole K17, K22 and K32 Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br338
b:56.3
occ:1.00
|
BR1
|
A:K32338
|
0.0
|
56.3
|
1.0
|
C5
|
A:K32338
|
1.9
|
52.5
|
1.0
|
C7
|
A:K32338
|
2.8
|
52.3
|
1.0
|
C2
|
A:K32338
|
2.9
|
52.3
|
1.0
|
N14
|
A:K32338
|
3.2
|
52.1
|
1.0
|
BR2
|
A:K32338
|
3.3
|
51.5
|
1.0
|
SD
|
A:MET163
|
3.5
|
27.3
|
1.0
|
CG2
|
A:VAL45
|
4.0
|
37.0
|
1.0
|
CB
|
A:VAL45
|
4.1
|
37.5
|
1.0
|
C8
|
A:K32338
|
4.1
|
52.7
|
1.0
|
ND2
|
A:ASN118
|
4.2
|
29.3
|
1.0
|
C3
|
A:K32338
|
4.2
|
52.9
|
1.0
|
CB
|
A:ASN118
|
4.3
|
31.9
|
1.0
|
O
|
A:VAL45
|
4.5
|
38.3
|
1.0
|
C13
|
A:K32338
|
4.5
|
52.8
|
1.0
|
CE
|
A:MET163
|
4.6
|
27.0
|
1.0
|
CG
|
A:ASN118
|
4.6
|
31.1
|
1.0
|
C4
|
A:K32338
|
4.6
|
52.3
|
1.0
|
C
|
A:VAL45
|
4.8
|
38.0
|
1.0
|
CG
|
A:MET163
|
4.9
|
26.4
|
1.0
|
CG1
|
A:VAL45
|
4.9
|
37.1
|
1.0
|
CD1
|
A:ILE66
|
5.0
|
33.0
|
1.0
|
|
Bromine binding site 2 out
of 4 in 2oxd
Go back to
Bromine Binding Sites List in 2oxd
Bromine binding site 2 out
of 4 in the Protein Kinase CK2 in Complex with Tetrabromobenzoimidazole K17, K22 and K32 Inhibitors
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 2 of Protein Kinase CK2 in Complex with Tetrabromobenzoimidazole K17, K22 and K32 Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br338
b:51.5
occ:1.00
|
BR2
|
A:K32338
|
0.0
|
51.5
|
1.0
|
C2
|
A:K32338
|
1.9
|
52.3
|
1.0
|
O
|
A:VAL116
|
2.8
|
31.8
|
1.0
|
C5
|
A:K32338
|
2.8
|
52.5
|
1.0
|
C3
|
A:K32338
|
2.8
|
52.9
|
1.0
|
BR1
|
A:K32338
|
3.3
|
56.3
|
1.0
|
BR4
|
A:K32338
|
3.3
|
52.6
|
1.0
|
CD1
|
A:ILE66
|
3.7
|
33.0
|
1.0
|
CB
|
A:VAL116
|
3.7
|
31.4
|
1.0
|
C
|
A:VAL116
|
3.7
|
31.9
|
1.0
|
SD
|
A:MET163
|
3.8
|
27.3
|
1.0
|
N
|
A:VAL116
|
3.8
|
31.4
|
1.0
|
CG1
|
A:ILE66
|
3.9
|
32.3
|
1.0
|
CA
|
A:VAL116
|
4.0
|
31.6
|
1.0
|
CB
|
A:ASN118
|
4.1
|
31.9
|
1.0
|
CG
|
A:MET163
|
4.1
|
26.4
|
1.0
|
C4
|
A:K32338
|
4.1
|
52.3
|
1.0
|
C7
|
A:K32338
|
4.1
|
52.3
|
1.0
|
N
|
A:ASN118
|
4.5
|
32.4
|
1.0
|
CG2
|
A:VAL116
|
4.5
|
31.9
|
1.0
|
CG1
|
A:VAL116
|
4.6
|
31.1
|
1.0
|
CB
|
A:MET163
|
4.7
|
26.5
|
1.0
|
C8
|
A:K32338
|
4.7
|
52.7
|
1.0
|
CD1
|
A:TYR115
|
4.8
|
29.7
|
1.0
|
CE1
|
A:TYR115
|
4.9
|
30.6
|
1.0
|
CA
|
A:ASN118
|
5.0
|
32.2
|
1.0
|
N
|
A:ASN117
|
5.0
|
32.2
|
1.0
|
|
Bromine binding site 3 out
of 4 in 2oxd
Go back to
Bromine Binding Sites List in 2oxd
Bromine binding site 3 out
of 4 in the Protein Kinase CK2 in Complex with Tetrabromobenzoimidazole K17, K22 and K32 Inhibitors
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 3 of Protein Kinase CK2 in Complex with Tetrabromobenzoimidazole K17, K22 and K32 Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br338
b:51.4
occ:1.00
|
BR3
|
A:K32338
|
0.0
|
51.4
|
1.0
|
C4
|
A:K32338
|
1.9
|
52.3
|
1.0
|
C8
|
A:K32338
|
2.8
|
52.7
|
1.0
|
C3
|
A:K32338
|
2.8
|
52.9
|
1.0
|
O
|
A:HOH344
|
3.2
|
13.9
|
1.0
|
N6
|
A:K32338
|
3.2
|
52.4
|
1.0
|
BR4
|
A:K32338
|
3.4
|
52.6
|
1.0
|
CD2
|
A:PHE113
|
3.6
|
24.1
|
1.0
|
CG2
|
A:ILE174
|
3.8
|
26.9
|
1.0
|
CG2
|
A:ILE66
|
3.9
|
32.4
|
1.0
|
CB
|
A:ILE174
|
3.9
|
26.8
|
1.0
|
CG
|
A:PHE113
|
4.0
|
26.9
|
1.0
|
CE2
|
A:PHE113
|
4.0
|
22.8
|
1.0
|
CD1
|
A:ILE174
|
4.1
|
25.9
|
1.0
|
C7
|
A:K32338
|
4.1
|
52.3
|
1.0
|
C2
|
A:K32338
|
4.1
|
52.3
|
1.0
|
CG2
|
A:VAL95
|
4.4
|
30.5
|
1.0
|
CB
|
A:PHE113
|
4.4
|
27.8
|
1.0
|
C13
|
A:K32338
|
4.5
|
52.8
|
1.0
|
CG1
|
A:ILE174
|
4.6
|
26.0
|
1.0
|
C5
|
A:K32338
|
4.6
|
52.5
|
1.0
|
CD1
|
A:PHE113
|
4.6
|
26.2
|
1.0
|
CZ
|
A:PHE113
|
4.7
|
24.2
|
1.0
|
CB
|
A:ILE66
|
4.8
|
32.5
|
1.0
|
CE1
|
A:PHE113
|
4.9
|
24.3
|
1.0
|
N14
|
A:K32338
|
5.0
|
52.1
|
1.0
|
|
Bromine binding site 4 out
of 4 in 2oxd
Go back to
Bromine Binding Sites List in 2oxd
Bromine binding site 4 out
of 4 in the Protein Kinase CK2 in Complex with Tetrabromobenzoimidazole K17, K22 and K32 Inhibitors
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 4 of Protein Kinase CK2 in Complex with Tetrabromobenzoimidazole K17, K22 and K32 Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br338
b:52.6
occ:1.00
|
BR4
|
A:K32338
|
0.0
|
52.6
|
1.0
|
C3
|
A:K32338
|
1.9
|
52.9
|
1.0
|
C2
|
A:K32338
|
2.9
|
52.3
|
1.0
|
C4
|
A:K32338
|
2.9
|
52.3
|
1.0
|
O
|
A:GLU114
|
3.3
|
30.8
|
1.0
|
BR2
|
A:K32338
|
3.3
|
51.5
|
1.0
|
CG1
|
A:ILE66
|
3.3
|
32.3
|
1.0
|
BR3
|
A:K32338
|
3.4
|
51.4
|
1.0
|
CB
|
A:ILE66
|
3.9
|
32.5
|
1.0
|
CG2
|
A:VAL116
|
4.0
|
31.9
|
1.0
|
CG2
|
A:ILE66
|
4.1
|
32.4
|
1.0
|
C5
|
A:K32338
|
4.2
|
52.5
|
1.0
|
CG2
|
A:VAL95
|
4.2
|
30.5
|
1.0
|
C8
|
A:K32338
|
4.2
|
52.7
|
1.0
|
N
|
A:VAL116
|
4.3
|
31.4
|
1.0
|
CD1
|
A:ILE66
|
4.3
|
33.0
|
1.0
|
CB
|
A:VAL116
|
4.3
|
31.4
|
1.0
|
CG2
|
A:ILE174
|
4.3
|
26.9
|
1.0
|
CG
|
A:MET163
|
4.4
|
26.4
|
1.0
|
C
|
A:GLU114
|
4.5
|
30.5
|
1.0
|
CB
|
A:PHE113
|
4.5
|
27.8
|
1.0
|
C7
|
A:K32338
|
4.8
|
52.3
|
1.0
|
CA
|
A:TYR115
|
4.8
|
31.1
|
1.0
|
C
|
A:TYR115
|
4.8
|
31.6
|
1.0
|
CA
|
A:VAL116
|
4.9
|
31.6
|
1.0
|
|
Reference:
R.Battistutta,
M.Mazzorana,
L.Cendron,
A.Bortolato,
S.Sarno,
Z.Kazimierczuk,
G.Zanotti,
S.Moro,
L.A.Pinna.
The Atp-Binding Site of Protein Kinase CK2 Holds A Positive Electrostatic Area and Conserved Water Molecules. Chembiochem V. 8 1804 2007.
ISSN: ISSN 1439-4227
PubMed: 17768728
DOI: 10.1002/CBIC.200700307
Page generated: Wed Jul 10 18:19:43 2024
|